DK364286D0 - Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse - Google Patents

Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse

Info

Publication number
DK364286D0
DK364286D0 DK364286A DK364286A DK364286D0 DK 364286 D0 DK364286 D0 DK 364286D0 DK 364286 A DK364286 A DK 364286A DK 364286 A DK364286 A DK 364286A DK 364286 D0 DK364286 D0 DK 364286D0
Authority
DK
Denmark
Prior art keywords
glycoproteines
vzv
varicella
denatured
antibodies
Prior art date
Application number
DK364286A
Other languages
English (en)
Other versions
DK364286A (da
Inventor
Ronald W Ellis
Beverly J Neff
Paul M Keller
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK364286D0 publication Critical patent/DK364286D0/da
Publication of DK364286A publication Critical patent/DK364286A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK364286A 1985-08-01 1986-07-31 Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse DK364286A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76124585A 1985-08-01 1985-08-01
US76124885A 1985-08-01 1985-08-01
US76124685A 1985-08-01 1985-08-01

Publications (2)

Publication Number Publication Date
DK364286D0 true DK364286D0 (da) 1986-07-31
DK364286A DK364286A (da) 1987-03-20

Family

ID=27419540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK364286A DK364286A (da) 1985-08-01 1986-07-31 Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse

Country Status (4)

Country Link
EP (1) EP0211756A1 (da)
JP (1) JPH0222298A (da)
DK (1) DK364286A (da)
ES (1) ES2001864A6 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769239A (en) * 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
GB8707839D0 (en) * 1987-04-02 1987-05-07 Secr Social Service Brit Immunoglobulin assay method
EP0405867B1 (en) * 1989-06-27 1995-03-15 SMITHKLINE BEECHAM BIOLOGICALS s.a. Novel compounds
US5650319A (en) * 1990-04-20 1997-07-22 Teijin Limited Human monoclonal antibody to glycoprotein GPIII of varicella zoster virus
AU687355B2 (en) 1992-07-17 1998-02-26 Merck Sharp & Dohme Corp. Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
CA2177060A1 (en) * 1993-12-21 1995-06-29 Philip J. Provost Thermostable varicella zoster virus
KR100374308B1 (ko) * 1995-07-27 2003-12-18 주식회사 엘지생명과학 재조합차이니스햄스터오바리세포로부터발현된수두바이러스의지피i당단백질의정제방법
US20200088721A1 (en) * 2016-01-27 2020-03-19 J-Oil Mills, Inc. Glycoprotein assay method
CN112386688B (zh) * 2021-01-20 2021-09-24 广东新征程生命科学有限公司 一种用于病毒治疗的含有免疫细胞的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS206823B1 (en) * 1979-04-28 1981-07-31 Karel Filka Sorbents for saccharides,glycoproteins and polymers,containing saccharides and method of their manufacture
US4457865A (en) * 1982-03-08 1984-07-03 Research Corporation Sialic acid specific slug lectin

Also Published As

Publication number Publication date
EP0211756A1 (en) 1987-02-25
ES2001864A6 (es) 1988-07-01
DK364286A (da) 1987-03-20
JPH0222298A (ja) 1990-01-25

Similar Documents

Publication Publication Date Title
DK164687C (da) Fremgangsmaade til sterilisering af gasimpermeable overflader med chlordioxid
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
DK163840C (da) Fremgangsmaade til bestemmelse af antigener ved hjaelp af to eller flere monoklonale antistoffer og proeveudstyr til brug ved fremgangsmaaden
DE3483512D1 (de) Deletionsmutant eines herpesvirus und dieses virus enthaltendes vakzin.
DK155665C (da) Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
DK82784D0 (da) Fremgangsmade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
DK194984D0 (da) Apparat til gastilsaetning til vaesker
DK364286A (da) Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse
DK433781A (da) Fremgangsmaade til fremstilling af n-(2-pyrimidinyl) piperazinylalkylazespiroalkadioner
DK553281A (da) Fremgangsmaade til paavisning af antistof
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
DK204884D0 (da) Gaerudtrykkelsesmedium,gaerorganisme transformeret dermed og fremgangsmaade til fremstilling af et for gaer heterologt protein
DK260186A (da) Fremgangsmaade til fjernelse af det n-terminale metionin fra metionylproteiner
DK404888D0 (da) Fremgangsmaade til rensning af arsenholdige afgangsgasser
DK228081A (da) Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner
DK0544805T3 (da) Fremgangsmåder til hormondetektering
DK93684D0 (da) Fremgangsmade til adjuvering af oliefri vacciner
DK283579A (da) Fremgangsmaade i gsmaade til fremstilling af praeparater af disse
DK162688C (da) Fremgangsmaade til fremstilling af valleprotein med forbedret geldannelsesevne
DK198688D0 (da) Fremgangsmaade til maaling af polariserede fluorescensemissioner
FI874273L (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
IT1141277B (it) Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione
DK58081A (da) Fremgangsmaade til fremstilling af peptider under beskyttelse af en guanidinogruppe samt gendannelse deraf
DK283883A (da) Fremgangsmaade, reagenssaet og apparat til paavisning af yverbetaendelse
FI952779L (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment